Keller Graduate School of management
As equity investors caught up in the cannabis craze push pot stocks to record highs, options traders are paying the most ever to hedge against a comedown.
As Biogen Inc. prepares to kick off earnings season Tuesday for a beaten-down large-cap biotechnology sector, investors won’t be too focused on the financial results.
Amazon announced today that it has signed an agreement to acquire PillPack, an online pharmacy that offers pre-sorted doses of medications, home delivery, and a commitment to customer service
Philips (PHG.AS) is worried about rising trade tensions between the United States and China, said the Dutch health-technology company that is banking on continuing Chinese demand for its high-end medical equipment.
Equities have greeted 2018 with a bang, but none more so than Korean pharmaceutical maker Celltrion Inc., which has piled on about 9 trillion won ($8.4 billion) of market value in just seven days.
Pharm Exec's latest annual listing of the top biopharma players paints a stable picture of performance for the usual placeholders, but change and disruption to current business models could upend positioning in the years ahead.
On Thursday the major markets closed in green zone again. DJIA +0.73%, Nasdaq +0.57%, S&P500 +0.53%! Biotech market also has raised: NASDAQ Biotechnology (NBI) +0.33%! Shares of Prothena Corporation plc (PRTA) +5.02% and Foamix Pharmaceuticals Ltd (FOMX) +7.12% had raised. Shares of Immune Desi (IMDZ) -6.53% and XBiotech Inc. (XBIT) -15.49% had fallen! Sage Therapeutic (SAGE) stocks increased $0.45 and closed at $6.77 (+7.12%). The trading volume exceeded 5 times the average trading: 534K vs. 164K. The company's capitalization was $208M. The minimum FOMX share price: $5.48, while the maximum price: $12.20.
The first day of the week demonstrated various market indexes: DJIA -0.10%, NASDAQ: + 0.14%, S & P500 -0.04%. Biotech showed a slight increase: NASDAQ Biotechnology (^ NBI) + 0.49%.
